SCHEMBL4136868

SCHEMBL4136868

CCCc1nn(C)c2c(=O)[nH]c(N(CCc3ccc(Cl)cc3)CC3CCCCC3)nc12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 13/20 0.44
PDE3A Q14432 3/20 0.44
PDE3B Q13370 2/20 0.44
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40
KMT2A Q03164 1/20 0.40
PDE1C Q14123 1/20 0.40
MTOR P42345 1/20 0.39
TERT O14746 2/20 0.39
HDAC6 Q9UBN7 4/20 0.39
HDAC1 Q13547 3/20 0.39
CHIT1 Q13231 1/20 0.37
CHIA Q9BZP6 1/20 0.37
PDE6C P51160 1/20 0.36
CRHR1 P34998 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4899916 0.86 PDE5A (0.50) PDE5APDE3APDE3BMEN1ALDH1A1
SCHEMBL8049072 0.86 PDE5A (0.48) PDE5APDE3APDE3BMEN1ALDH1A1
SCHEMBL4132769 0.85 PDE5A (0.42) PDE5APDE3APDE3BMEN1ALDH1A1
SCHEMBL4128439 0.84 PDE5A (0.42) PDE5APDE3APDE3BMEN1ALDH1A1
SCHEMBL3993298 0.82 PDE5A (0.44) PDE5APDE3APDE3BMEN1ALDH1A1
SCHEMBL8045086 0.80 PDE5A (0.47) PDE5APDE3APDE3BMEN1ALDH1A1
SCHEMBL8047604 0.79 PDE5A (0.42) PDE5APDE3APDE3BMEN1ALDH1A1
SCHEMBL8037857 0.78 PDE5A (0.42) PDE5APDE3APDE3BMEN1ALDH1A1
SCHEMBL8050917 0.77 PDE5A (0.44) PDE5APDE3APDE3BMEN1ALDH1A1
SCHEMBL8047597 0.77 PDE5A (0.38) PDE5APDE3APDE3BMTORHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed